Warning! The directory is not yet complete and will be amended until the beginning of the term.
322019 VU Gender- and Chronopharmacokinetics - M11 (2019S)
Continuous assessment of course work
Labels
Vorlesungszeiten:
Czejka: 06.05./07.05./13.05.2019 13.15-14.45 Uhr HS 5
Farkouh: 17.05./20.05./21.05./27.05.2019 13.15-14.45 Uhr HS 5Prüfungstermin:
07.06.2019 13.15 s.t. HS 5
Weitere Prüfungstermine werden bei Bedarf abgehalten
Czejka: 06.05./07.05./13.05.2019 13.15-14.45 Uhr HS 5
Farkouh: 17.05./20.05./21.05./27.05.2019 13.15-14.45 Uhr HS 5Prüfungstermin:
07.06.2019 13.15 s.t. HS 5
Weitere Prüfungstermine werden bei Bedarf abgehalten
Details
Language: German
Lecturers
Classes (iCal) - next class is marked with N
gemeinsam mit Dr. med. Mag. pharm. Dr. Andre Farkouh
Monday
06.05.
13:15 - 14:45
UZA2 Hörsaal 5 (Raum 2Z202) 2.OG
Tuesday
07.05.
13:15 - 14:45
UZA2 Hörsaal 5 (Raum 2Z202) 2.OG
Monday
13.05.
13:15 - 14:45
UZA2 Hörsaal 5 (Raum 2Z202) 2.OG
Friday
17.05.
13:15 - 14:45
UZA2 Hörsaal 5 (Raum 2Z202) 2.OG
Monday
20.05.
13:15 - 14:45
UZA2 Hörsaal 5 (Raum 2Z202) 2.OG
Tuesday
21.05.
13:15 - 14:45
UZA2 Hörsaal 5 (Raum 2Z202) 2.OG
Monday
27.05.
13:15 - 14:45
UZA2 Hörsaal 5 (Raum 2Z202) 2.OG
Friday
07.06.
13:15 - 14:45
UZA2 Hörsaal 5 (Raum 2Z202) 2.OG
Information
Aims, contents and method of the course
Assessment and permitted materials
WRitten examination together with Dr. Dr. Farkouh
Sehr gut: 24-23 points
Gut: 22-20 poins
Befriedigend: 19-17 points
Genügend: 16-14 points
Nicht genügend: 13 points or less
Sehr gut: 24-23 points
Gut: 22-20 poins
Befriedigend: 19-17 points
Genügend: 16-14 points
Nicht genügend: 13 points or less
Minimum requirements and assessment criteria
basic pharmacokinetics
physiology
biochemistry
physiology
biochemistry
Examination topics
Reading list
Association in the course directory
A400, MA19
Last modified: Sa 02.04.2022 00:27
1.1. Rcompartment pharmacokinetics
1.2. clinical trials - inclusion of women
1.3. hormone status of women and men: sex versus gender
1.4. differences in physiology: women versus men
1.5. LADME deifferences: women versus men
1.6. gender aspects in drug therapy including consequences
1.7. pharmacokinetics during pregnancy
1.8. fetal pharmacokinetics
1.9. axamples2. Chronopharmacokinetics
2.1.biologic processes and rhythms
2.2. impact on LADME system
2.3. consequences for drug therapy - chronomodulated therapies
2.4. examples